LaTanya Parker

LaTanya Parker serves as a Contract Specialist at the Naval Medical Research Center (N32398), where she plays a pivotal role in executing mission-critical acquisitions that support the health and operational readiness of U.S. Navy and Marine Corps personnel. She manages a diverse portfolio of procurements focused on biomedical research, diagnostic innovation, and field-deployable medical technologies, ensuring compliance with federal acquisition regulations and alignment with force health protection priorities. Her work spans the full acquisition lifecycle—from market research and solicitation development to contract award and administration—enabling the rapid translation of scientific advancements into operational capabilities for austere environments. Parker maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, a key contractor providing specialized laboratory and diagnostic support services. Her contracting patterns reflect a preference for established technical partners with proven expertise in biomedical instrumentation and analytical systems, fostering long-term vendor collaboration grounded in technical reliability and regulatory compliance. While she engages with a range of vendors, her procurement approach emphasizes performance-based outcomes and technical capability over volume-based sourcing. Her contracting activity is overwhelmingly non-set-aside, with 88.5% of awards issued under full and open competition, reflecting the specialized nature of the technologies required. However, she actively supports small business participation through Total Small Business Set-Asides (11.5%), aligning with FAR 19.5 to ensure equitable access for qualified small entities capable of meeting rigorous scientific and technical requirements. Parker’s primary NAICS focus areas include 811219 (Other Commercial and Industrial Machinery and Equipment Repair), 541714 (Biotechnology Research and Development), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 334516 (Analytical Laboratory Instrument Manufacturing. These reflect her deep engagement with the development and procurement of diagnostic assays, laboratory-grade analytical instruments, and field-deployable biosensors critical to infectious disease surveillance and point-of-care medical readiness.